Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer All Other Hospital [legacy through FY25] by Quarter
All Other Hospital [legacy through FY25] ($M) ($M)
Pfizer All Other Hospital [legacy through FY25]: $1,059M in Q4 2025, down 2.4% from a year earlier.
Latest, Q4 2025
1,059
Period ended Dec 31, 2025
Change on a year earlier
-2.4%
1,085 in Q4 2024
History
30 quarters
Since Q1 2018
Sources
20
Documents cited below
Where the Q4 2025 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer All Other Hospital [legacy through FY25] ($M), quarterly Q1 2018–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/other-hosp-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.